The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth
Xu, Fei-Fei, Sun, Hui-Min, Fang, Run-Ping, Zhang, Lu, Shi, Hui, Wang, Xue, Fu, Xue-Li, Li, Xian-Meng, Shi, Xu-He, Wu, Yue, Ye, Kai, Zhang, Wei-Ying, Ye, Li-Hong
Published in Acta pharmacologica Sinica (01.02.2022)
Published in Acta pharmacologica Sinica (01.02.2022)
Get full text
Journal Article
The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways
Li, Hang, Wang, Zhen, Jiang, Mian, Fang, Run-Ping, Shi, Hui, Shen, Yu, Cai, Xiao-Li, Liu, Qian, Ye, Kai, Fan, Sai-Jun, Zhang, Wei-Ying, Ye, Li-Hong
Published in Acta pharmacologica Sinica (01.11.2018)
Published in Acta pharmacologica Sinica (01.11.2018)
Get full text
Journal Article